ImmuCell Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ICCC Nasdaq 2830 immucell.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ImmuCell Corporation

ImmuCell Q1 Earnings Rise Y/Y as Sales Climb on Strong Demand - May 25th, 2026 7:45 am
ImmuCell Corp (ICCC) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth - May 15th, 2026 5:01 pm
ImmuCell Q1 Earnings Call Highlights - May 15th, 2026 9:06 am
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026 - May 14th, 2026 2:05 pm
Here’s Why ImmuCell Corporation (ICCC) is Emerging as an Intriguing Micro-Cap Opportunity - May 13th, 2026 2:18 am
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026 - May 7th, 2026 2:05 pm
The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell - Apr 22nd, 2026 1:59 am
Top Stock Reports for Goldman Sachs, NextEra Energy & Shopify - Apr 21st, 2026 2:17 pm
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors - Apr 13th, 2026 2:38 pm
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results - Apr 8th, 2026 2:05 pm
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board - Mar 18th, 2026 2:05 pm
ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges - Mar 6th, 2026 6:02 pm
ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve - Mar 6th, 2026 10:43 am
ImmuCell Q4 Earnings Call Highlights - Mar 5th, 2026 7:07 pm
ImmuCell Corporation Q4 2025 Earnings Call Summary - Mar 5th, 2026 6:30 am
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 - Mar 4th, 2026 2:05 pm
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 - Feb 18th, 2026 6:37 am
Niche Focus & Regulation Shape the Future of Healthcare Firms - Jan 15th, 2026 9:24 am
Those who invested in ImmuCell (NASDAQ:ICCC) a year ago are up 25% - Jan 12th, 2026 6:02 am
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 - Jan 8th, 2026 2:05 pm